Global Regenerative Medicines Market 2022-2026

The publisher has been monitoring the regenerative medicines market and it is poised to grow by $28.67 bn during 2022-2026, accelerating at a CAGR of 14.57% during the forecast period. The report on the regenerative medicines market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of chronic diseases, increasing support from the public and private healthcare organizations, and increasing the adoption of stem cell therapy.

The regenerative medicines market analysis includes the technology segment and geographic landscape.

The regenerative medicines market is segmented as below:

By Technology

Cell and tissue-based
Gene therapy

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increasing number of clinical trials as one of the prime reasons driving the regenerative medicines market growth during the next few years. Also, emerging technological advances and strategic partnerships and acquisitions will lead to sizable demand in the market.

The report on the regenerative medicines market covers the following areas:

Regenerative medicines market sizing
Regenerative medicines market forecast
Regenerative medicines market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading regenerative medicines market vendors that include AbbVie Inc., Amgen Inc., Baxter International Inc., Becton Dickinson, and Co., Cook Group Inc., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., Integra Lifesciences Corp., Johnson and Johnson, Medtronic Plc, Merck and Co. Inc., Mesoblast Ltd., MiMedx Group Inc., Novartis AG, Nuvasive Inc., Organogenesis Inc., Smith and Nephew plc, Thermo Fisher Scientific Inc., Vericel Corp., and Zimmer Biomet Holdings Inc. Also, the regenerative medicines market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Technology
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Technology

5.1 Market segments
Exhibit 24: Chart on Technology - Market share 2021-2026 (%)
Exhibit 25: Data Table on Technology - Market share 2021-2026 (%)
5.2 Comparison by Technology
Exhibit 26: Chart on Comparison by Technology
Exhibit 27: Data Table on Comparison by Technology
5.3 Cell and tissue-based - Market size and forecast 2021-2026
Exhibit 28: Chart on Cell and tissue-based - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Cell and tissue-based - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Cell and tissue-based - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Cell and tissue-based - Year-over-year growth 2021-2026 (%)
5.4 Gene therapy - Market size and forecast 2021-2026
Exhibit 32: Chart on Gene therapy - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Gene therapy - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Gene therapy - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Gene therapy - Year-over-year growth 2021-2026 (%)
5.5 Market opportunity by Technology
Exhibit 36: Market opportunity by Technology ($ million)

6 Customer Landscape

6.1 Customer landscape overview
Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

7.1 Geographic segmentation
Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 40: Chart on Geographic comparison
Exhibit 41: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Germany - Market size and forecast 2021-2026
Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.9 Japan - Market size and forecast 2021-2026
Exhibit 66: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on Japan - Year-over-year growth 2021-2026 (%)
7.10 UK - Market size and forecast 2021-2026
Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.11 China - Market size and forecast 2021-2026
Exhibit 74: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on China - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 78: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 79: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends

9 Vendor Landscape

9.1 Overview
9.2 Vendor landscape
Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 81: Overview on factors of disruption
9.4 Industry risks
Exhibit 82: Impact of key risks on business

10 Vendor Analysis

10.1 Vendors covered
Exhibit 83: Vendors covered
10.2 Market positioning of vendors
Exhibit 84: Matrix on vendor position and classification
10.3 AbbVie Inc.
Exhibit 85: AbbVie Inc. - Overview
Exhibit 86: AbbVie Inc. - Product/Service
Exhibit 87: AbbVie Inc. - Key offerings
10.4 Baxter International Inc.
Exhibit 88: Baxter International Inc. - Overview
Exhibit 89: Baxter International Inc. - Business segments
Exhibit 90: Baxter International Inc. - Key news
Exhibit 91: Baxter International Inc. - Key offerings
Exhibit 92: Baxter International Inc. - Segment focus
10.5 Becton Dickinson and Co.
Exhibit 93: Becton Dickinson and Co. - Overview
Exhibit 94: Becton Dickinson and Co. - Business segments
Exhibit 95: Becton Dickinson and Co. - Key news
Exhibit 96: Becton Dickinson and Co. - Key offerings
Exhibit 97: Becton Dickinson and Co. - Segment focus
10.6 Cook Group Inc.
Exhibit 98: Cook Group Inc. - Overview
Exhibit 99: Cook Group Inc. - Product/Service
Exhibit 100: Cook Group Inc. - Key offerings
10.7 Integra LifeSciences Corp.
Exhibit 101: Integra LifeSciences Corp. - Overview
Exhibit 102: Integra LifeSciences Corp. - Business segments
Exhibit 103: Integra LifeSciences Corp. - Key news
Exhibit 104: Integra LifeSciences Corp. - Key offerings
Exhibit 105: Integra LifeSciences Corp. - Segment focus
10.8 Medtronic Plc
Exhibit 106: Medtronic Plc - Overview
Exhibit 107: Medtronic Plc - Business segments
Exhibit 108: Medtronic Plc - Key news
Exhibit 109: Medtronic Plc - Key offerings
Exhibit 110: Medtronic Plc - Segment focus
10.9 Merck and Co. Inc.
Exhibit 111: Merck and Co. Inc. - Overview
Exhibit 112: Merck and Co. Inc. - Business segments
Exhibit 113: Merck and Co. Inc. - Key news
Exhibit 114: Merck and Co. Inc. - Key offerings
Exhibit 115: Merck and Co. Inc. - Segment focus
10.10 Organogenesis Inc.
Exhibit 116: Organogenesis Inc. - Overview
Exhibit 117: Organogenesis Inc. - Product/Service
Exhibit 118: Organogenesis Inc. - Key offerings
10.11 Smith and Nephew plc
Exhibit 119: Smith and Nephew plc - Overview
Exhibit 120: Smith and Nephew plc - Business segments
Exhibit 121: Smith and Nephew plc - Key news
Exhibit 122: Smith and Nephew plc - Key offerings
Exhibit 123: Smith and Nephew plc - Segment focus
10.12 Thermo Fisher Scientific Inc.
Exhibit 124: Thermo Fisher Scientific Inc. - Overview
Exhibit 125: Thermo Fisher Scientific Inc. - Business segments
Exhibit 126: Thermo Fisher Scientific Inc. - Key news
Exhibit 127: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 128: Thermo Fisher Scientific Inc. - Segment focus

11 Appendix

11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 129: Inclusions checklist
Exhibit 130: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 131: Currency conversion rates for US$
11.4 Research methodology
Exhibit 132: Research methodology
Exhibit 133: Validation techniques employed for market sizing
Exhibit 134: Information sources
11.5 List of abbreviations
Exhibit 135: List of abbreviations

List of Exhibits

Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Technology
Exhibits 6: Executive Summary - Chart on Incremental Growth
Exhibits 7: Executive Summary - Data Table on Incremental Growth
Exhibits 8: Executive Summary - Chart on Vendor Market Positioning
Exhibits 9: Parent market
Exhibits 10: Market Characteristics
Exhibits 11: Offerings of vendors included in the market definition
Exhibits 12: Market segments
Exhibits 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits 17: Five forces analysis - Comparison between2021 and 2026
Exhibits 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits 20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits 21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits 22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits 23: Chart on Market condition - Five forces 2021 and 2026
Exhibits 24: Chart on Technology - Market share 2021-2026 (%)
Exhibits 25: Data Table on Technology - Market share 2021-2026 (%)
Exhibits 26: Chart on Comparison by Technology
Exhibits 27: Data Table on Comparison by Technology
Exhibits 28: Chart on Cell and tissue-based - Market size and forecast 2021-2026 ($ million)
Exhibits 29: Data Table on Cell and tissue-based - Market size and forecast 2021-2026 ($ million)
Exhibits 30: Chart on Cell and tissue-based - Year-over-year growth 2021-2026 (%)
Exhibits 31: Data Table on Cell and tissue-based - Year-over-year growth 2021-2026 (%)
Exhibits 32: Chart on Gene therapy - Market size and forecast 2021-2026 ($ million)
Exhibits 33: Data Table on Gene therapy - Market size and forecast 2021-2026 ($ million)
Exhibits 34: Chart on Gene therapy - Year-over-year growth 2021-2026 (%)
Exhibits 35: Data Table on Gene therapy - Year-over-year growth 2021-2026 (%)
Exhibits 36: Market opportunity by Technology ($ million)
Exhibits 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits 40: Chart on Geographic comparison
Exhibits 41: Data Table on Geographic comparison
Exhibits 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits 44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits 58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits 60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits 61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits 66: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits 67: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits 68: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibits 69: Data Table on Japan - Year-over-year growth 2021-2026 (%)
Exhibits 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits 72: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits 74: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits 75: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits 76: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits 77: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits 78: Market opportunity By Geographical Landscape ($ million)
Exhibits 79: Impact of drivers and challenges in 2021 and 2026
Exhibits 80: Overview on Criticality of inputs and Factors of differentiation
Exhibits 81: Overview on factors of disruption
Exhibits 82: Impact of key risks on business
Exhibits 83: Vendors covered
Exhibits 84: Matrix on vendor position and classification
Exhibits 85: AbbVie Inc. - Overview
Exhibits 86: AbbVie Inc. - Product/Service
Exhibits 87: AbbVie Inc. - Key offerings
Exhibits 88: Baxter International Inc. - Overview
Exhibits 89: Baxter International Inc. - Business segments
Exhibits 90: Baxter International Inc. - Key news
Exhibits 91: Baxter International Inc. - Key offerings
Exhibits 92: Baxter International Inc. - Segment focus
Exhibits 93: Becton Dickinson and Co. - Overview
Exhibits 94: Becton Dickinson and Co. - Business segments
Exhibits 95: Becton Dickinson and Co. - Key news
Exhibits 96: Becton Dickinson and Co. - Key offerings
Exhibits 97: Becton Dickinson and Co. - Segment focus
Exhibits 98: Cook Group Inc. - Overview
Exhibits 99: Cook Group Inc. - Product/Service
Exhibits 100: Cook Group Inc. - Key offerings
Exhibits 101: Integra LifeSciences Corp. - Overview
Exhibits 102: Integra LifeSciences Corp. - Business segments
Exhibits 103: Integra LifeSciences Corp. - Key news
Exhibits 104: Integra LifeSciences Corp. - Key offerings
Exhibits 105: Integra LifeSciences Corp. - Segment focus
Exhibits 106: Medtronic Plc - Overview
Exhibits 107: Medtronic Plc - Business segments
Exhibits 108: Medtronic Plc - Key news
Exhibits 109: Medtronic Plc - Key offerings
Exhibits 110: Medtronic Plc - Segment focus
Exhibits 111: Merck and Co. Inc. - Overview
Exhibits 112: Merck and Co. Inc. - Business segments
Exhibits 113: Merck and Co. Inc. - Key news
Exhibits 114: Merck and Co. Inc. - Key offerings
Exhibits 115: Merck and Co. Inc. - Segment focus
Exhibits 116: Organogenesis Inc. - Overview
Exhibits 117: Organogenesis Inc. - Product/Service
Exhibits 118: Organogenesis Inc. - Key offerings
Exhibits 119: Smith and Nephew plc - Overview
Exhibits 120: Smith and Nephew plc - Business segments
Exhibits 121: Smith and Nephew plc - Key news
Exhibits 122: Smith and Nephew plc - Key offerings
Exhibits 123: Smith and Nephew plc - Segment focus
Exhibits 124: Thermo Fisher Scientific Inc. - Overview
Exhibits 125: Thermo Fisher Scientific Inc. - Business segments
Exhibits 126: Thermo Fisher Scientific Inc. - Key news
Exhibits 127: Thermo Fisher Scientific Inc. - Key offerings
Exhibits 128: Thermo Fisher Scientific Inc. - Segment focus
Exhibits 129: Inclusions checklist
Exhibits 130: Exclusions checklist
Exhibits 131: Currency conversion rates for US$
Exhibits 132: Research methodology
Exhibits 133: Validation techniques employed for market sizing
Exhibits 134: Information sources
Exhibits 135: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global regenerative medicines market: AbbVie Inc., Amgen Inc., Baxter International Inc., Becton Dickinson and Co., Cook Group Inc., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., Integra Lifesciences Corp., Johnson and Johnson, Medtronic Plc, Merck and Co. Inc., Mesoblast Ltd., MiMedx Group Inc., Novartis AG, Nuvasive Inc., Organogenesis Inc., Smith and Nephew plc, Thermo Fisher Scientific Inc., Vericel Corp., and Zimmer Biomet Holdings Inc.

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increasing number of clinical trials."

According to the report, one of the major drivers for this market is the increasing prevalence of chronic diseases.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.